leisure time -WSS

leisure time

author：hotspot 2025-10-01 00:58:33 - browse：44489

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Flint parents haunted by uncertainty, fears of lead poisoning

WSS

Medical students need to learn the potent medicine of empathy

It costs an awful lot of money to give away a kidney

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

How to ethically and practically extend health care to all

Louisiana bill approved classifying abortion pills as controlled substances

focus

leisure time

hotspot

Apple is now the first public company to be valued at $3 trillion

A controversial new treatment promises to make little people taller

After affirmative action ruling, medical educators look to 'holistic review'

Some medical students still think black patients feel less pain

State Dept. review finds Biden bears some blame for Afghanistan failures

'Null' research findings aren't empty of meaning. Let's publish them

Activists slam private health insurers over coverage restrictions

Beyond aggravation: Constipation is an American epidemic

Peter Hotez and the public health issue of online harassment

FDA scientists endorse Pfizer/BioNTech Covid

explore

Ozempic cut risk of death in diabetes patients with chronic kidney disease

New research sheds light on how often breast cancer is overdiagnosed

Achieving telehealth equity for people with hearing loss

A controversial new treatment promises to make little people taller

Pharma’s losing bet in New Jersey

H.R. 3 is the wrong path to lower drug costs

entertainment

focus

hotspot

Wikipedia